Search results
Stocks to watch: Ambuja Cements, Maruti, Sun Pharma, M&M, Adani Power, Infosys | Stock Market News
Livemint· 1 hour agoHere are a few stocks likely to be in focus on Thursday, 1 August:
Sun Pharma Q1 Preview: Strong US, domestic sales to aid profit growth but high R&D to drag margins
CNBC Awaaz· 18 hours agoAccording to a Moneycontrol poll of 13 brokerages, Sun Pharma's revenue is pegged to grow slightly...
Q1 results today: ITC, Tata Motors among 88 companies will announce earnings on Thursday
The Economic Times· 1 hour agoThe first quarter earnings season is underway and as many as 88 companies will announce their...
Options Trade | An earning-based non-directional options strategy in Sun Pharmaceutical
CNBC Awaaz· 3 hours agoSun Pharmaceutical Industries is expected to remain sideways within our range. An Iron Condor trade...
Sun Pharma Q1 Preview: R&D spends to hit margins; profits may rise 10%
Business Standard India· 2 days agoAccording to analyst estimates compiled by Business Standard, Sun Pharma may see its average revenue...
Sun Pharma gets US FDA nod for its specialty drug against baldness
The Economic Times· 6 days agoSun Pharma on Friday announced that the USFDA approved Leqselvi (deuruxolitinib) 8 mg tablets for...
Sun Pharma receives US FDA approval for drug to treat alopecia areata
Business Standard India· 6 days agoAutoimmune disorder characterised by hair loss affects some 700,000 people in the US
Sun Pharma hits all time high on US FDA nod for alopecia drug 'Leqselvi'
Business Standard India· 6 days agoThis came after Sun Pharmaceuticals announced that the US Food and Drug Administration (USFDA) has...
Stock Radar | Pharma stocks are back in action; Sun Pharma likely to hit fresh highs: Ruchit Jain
The Economic Times· 6 days ago“The market seems to have entered a broad consolidation phase, and there is selective buying...
Sun Pharma share price hits 52-week high, despite getting sued by Australia’s Mayne Pharma, over...
Livemint· 7 days agoSun Pharmaceutical's share price hit its 52-week high on July 25, 2024, at ₹1,658.00, on NSE. Mayne ...